Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.
2.

Transdermal testosterone therapy in the treatment of male hypogonadism.

Ahmed SR, Boucher AE, Manni A, Santen RJ, Bartholomew M, Demers LM.

J Clin Endocrinol Metab. 1988 Mar;66(3):546-51.

PMID:
3350906
3.

Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.

Meikle AW, Mazer NA, Moellmer JF, Stringham JD, Tolman KG, Sanders SW, Odell WD.

J Clin Endocrinol Metab. 1992 Mar;74(3):623-8.

PMID:
1740497
4.

Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.

Wang C, Berman N, Longstreth JA, Chuapoco B, Hull L, Steiner B, Faulkner S, Dudley RE, Swerdloff RS.

J Clin Endocrinol Metab. 2000 Mar;85(3):964-9.

PMID:
10720024
5.

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.

Arver S, Dobs AS, Meikle AW, Caramelli KE, Rajaram L, Sanders SW, Mazer NA.

Clin Endocrinol (Oxf). 1997 Dec;47(6):727-37.

PMID:
9497881
6.

Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years.

Behre HM, von Eckardstein S, Kliesch S, Nieschlag E.

Clin Endocrinol (Oxf). 1999 May;50(5):629-35.

PMID:
10468929
8.

Substitution therapy of hypogonadal men with transdermal testosterone over one year.

Bals-Pratsch M, Langer K, Place VA, Nieschlag E.

Acta Endocrinol (Copenh). 1988 May;118(1):7-13.

PMID:
3133918
9.
10.

Which testosterone replacement therapy?

Cantrill JA, Dewis P, Large DM, Newman M, Anderson DC.

Clin Endocrinol (Oxf). 1984 Aug;21(2):97-107.

PMID:
6467640
11.

Treatment of primary hypogonadism in men by the transdermal administration of testosterone.

Findlay JC, Place V, Snyder PJ.

J Clin Endocrinol Metab. 1989 Feb;68(2):369-73.

PMID:
2493029
12.

Testosterone release from a subcutaneous, biodegradable microcapsule formulation (Viatrel) in hypogonadal men.

Amory JK, Anawalt BD, Blaskovich PD, Gilchriest J, Nuwayser ES, Matsumoto AM.

J Androl. 2002 Jan-Feb;23(1):84-91.

13.

[Scrotal testosterone patches: a good addition to therapeutic options for hypogonadal men].

Asscheman H, Gooren LJ.

Ned Tijdschr Geneeskd. 2000 Apr 29;144(18):847-50. Dutch.

PMID:
10816775
14.

A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males.

Korbonits M, Slawik M, Cullen D, Ross RJ, Stalla G, Schneider H, Reincke M, Bouloux PM, Grossman AB.

J Clin Endocrinol Metab. 2004 May;89(5):2039-43.

PMID:
15126518
15.
16.

Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial.

Kühnert B, Byrne M, Simoni M, Köpcke W, Gerss J, Lemmnitz G, Nieschlag E.

Eur J Endocrinol. 2005 Aug;153(2):317-26.

17.

Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.

Jockenhövel F, Blum WF, Vogel E, Englaro P, Müller-Wieland D, Reinwein D, Rascher W, Krone W.

J Clin Endocrinol Metab. 1997 Aug;82(8):2510-3.

PMID:
9253326
18.

Decline of plasma 5alpha-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels.

Gooren LJ, Saad F, Haide A, Yassin A.

Andrologia. 2008 Oct;40(5):298-302. doi: 10.1111/j.1439-0272.2008.00857.x.

PMID:
18811920
19.

Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.

Jockenhövel F, Vogel E, Kreutzer M, Reinhardt W, Lederbogen S, Reinwein D.

Clin Endocrinol (Oxf). 1996 Jul;45(1):61-71.

PMID:
8796140
20.

Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.

Wang C, Eyre DR, Clark R, Kleinberg D, Newman C, Iranmanesh A, Veldhuis J, Dudley RE, Berman N, Davidson T, Barstow TJ, Sinow R, Alexander G, Swerdloff RS.

J Clin Endocrinol Metab. 1996 Oct;81(10):3654-62.

PMID:
8855818

Supplemental Content

Support Center